All Cancer Microbiology articles
-
NewsStart-up EBViously announces its launch
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).
-
NewsResearchers find previously unknown links between microbial bile acids and the risk of colon cancer
Microbes living in our guts help us digest food by reshaping the bile acids that our livers produce for breaking down fats. It turns out that two of these microbially-modified bile acids may affect our risk — in opposite directions — for developing colon cancer. Source: Photo by ...
-
NewsA dial for tuning the immune system: Discovery sheds light on why COVID makes some sicker than others
A new study identifies an “immune system tuning dial,” which originated as a bug in the genetic code tens of millions of years ago. When this signaling goes awry and leads the body to under or overreact, people are more likely to develop severe or Long COVID.
-
NewsInitiative to start HPV vaccination at age 9 improved completion rates
A quality improvement program designed to increase earlier uptake of the human papillomavirus (HPV) vaccine raised vaccination rates significantly, according to a study.
-
NewsPossible colon cancer vaccine target uncovered in bacteria
Higher rates of certain cancers may be linked to two particular strains of bacteria. Targeting these with treatments or vaccines could help reduce the risk of colorectal, bladder, and prostate cancers.
-
NewsCommon food poison toxin speeds colon cancer spread
A toxin in the bacteria that’s one of the most common causes of foodborne illness accelerates the spread of colorectal tumors to other parts of the body, a study has found.
-
NewsCervical cancer deaths in young women plummet after introduction of HPV vaccine
Cervical cancer deaths have plunged dramatically among women under age 25, and researchers believe this is likely due to HPV vaccination.
-
NewsResearchers develop light-guided siRNA delivery system based on cyanobacteria
In a study published in Cell Reports Physical Science on Nov. 25, a research team led by Prof. Cai Lintao from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences reported its development of an innovative intelligent light-guided biohybrid system, the CTPA/siCSF1R system, to target tumor-associated ...
-
NewsScientists implicate a novel cellular protein in hepatitis A infection
Viruses have thrived in humans for tens of thousands of years, evolving to take advantage of the machinery of cells to replicate and survive inside us. Some can slip past our defenses and invade without even causing symptoms. Source: Shirasaki et al. (2024) (Left) Liver cells infected with ...
-
NewsProbiotic delivers anticancer drug to the gut
Researchers have engineered a probiotic that delivers immunotherapy directly to the gut to shrink tumors in mice, offering a potentially promising oral drug for hard-to-reach cancers.
-
NewsNew evidence links gut microbiome to chronic disease outcomes
A new review consolidates recent findings that demonstrate a causal role for the gut microbiome in the progression of multiple diseases, ranging from gastrointestinal conditions to immune-related and psychiatric disorders.
-
NewsStudy links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern China
Researchers have discovered a significant association between specific Epstein-Barr virus (EBV) variants and nasopharyngeal carcinoma (NPC), a cancer prevalent in southern China, where it is 20 times more common than in non-endemic regions of the world.
-
NewsScientists reveal significant burden of liver cancer attributable to hepatitis B and alcohol globally
A new study analyzes and compares the epidemiological trends of liver cancer attributed to hepatitis B (LCHB) and alcohol use (LCAL) over the past 32 years.
-
NewsGut dysbiosis and fecal microbiota transplantation in pancreatic cancer: Current status and perspectives
Emerging studies suggest that manipulating the microbiome, including fecal microbiota transplantation, could present novel approaches to screening, diagnosing, and even treating pancreatic ductal adenocarcinoma.
-
NewsCaterpillar fungus that inspired ‘The Last of Us’ can slow down growth of cancer cells
New research into a chemical produced by a caterpillar fungus that has shown promise as a possible cancer treatment has revealed how it interacts with genes to interrupt cell growth signals.
-
NewsScientists discover how specific E. coli bacteria drive colon cancer
Scientists have uncovered how certain E. coli bacteria in the gut promote colon cancer by binding to intestinal cells and releasing a DNA-damaging toxin.
-
NewsStudy reveals insights into oral HPV incidence and risks in men across 3 countries
A new study has unveiled crucial information about the incidence and risk factors of oral human papillomavirus (HPV) infections among men in the United States, Mexico and Brazil - the virus is linked to up to 90% of all oropharyngeal cancer cases in men in the U.S.
-
NewsPlant fungus provides colorectal cancer drug with a new cellular target
A compound derived from a plant fungus effectively kills colorectal cancer cells by attacking the enzyme DCTPP1, which thus may serve as a potential biomarker for colorectal cancer and a therapeutic target.
-
NewsBacterial vaccine shows promise as cancer immunotherapy
Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
-
NewsNew bacteria-based therapy shows promise for fighting cancer
Researchers have developed a novel method to enhance the cancer-killing properties of bacteria residing in tumors.
